Andrew Kimball, Executive Vice President of Strategic Commercial Relationships at Velocity Clinical Research, highlights the growth and initiatives of his organization, which is currently the largest dedicated research site organization in the world. Andrew also shares insight on Velocity's acquisition of Meridian Clinical Research and the benefits of joining a site network.